Banquets and billions

Today's recommended read comes from my colleague Maggie Fick, who writes about how AstraZeneca CEO Pascal Soriot maneuvered to shield his Anglo-Swedish company from threatened steep tariffs on imports to the world's largest pharmaceuticals market.

Sources close to the negotiations told Reuters that Friday's medicine deal between AstraZeneca and the US government was the result of public and private meetings between Soriot and Trump officials, stretching back to November last year when Trump won the election.

Reuters One Essential Read is sent three days a week. Think your friend or colleague should know about us? Forward this newsletter to them. They can also sign up here.

Want to stop receiving this email? Unsubscribe here. To manage which newsletters you're signed up for, click here.

This email includes limited tracking for Reuters to understand whether you've engaged with its contents. For more information on how we process your personal information and your rights, please see our Privacy Statement.

Terms & Conditions